Andrew Green is a Devex Contributing Reporter based in Berlin. His coverage focuses primarily on health and human rights and he has previously worked as Voice of America's South Sudan bureau chief and the Center for Public Integrity's web editor.
A proposal introduced by South Africa and India seeks to waive intellectual property protections for COVID-19 vaccines and other technologies. Andrew Green looks at why some high-income countries are trying to stop it from being passed.
Researchers and funders are grappling with — and trying to redress — the lack of diversity in clinical trials for COVID-19 treatments and vaccines. Devex analyzes the latest interventions that seek to bridge this crucial gap.
A randomized controlled trial in Kenya sparks concerns about whether marginalized communities lost access to water for the sake of an experiment. Now more people are asking how these trials are conducted and who is involved.
Rather than framing the climate and health crises as separate or competing for scarce resources, experts say there is an opportunity to leverage funding to simultaneously make communities more resilient to both pandemics and climate change.